This suggested that ACE-like factors might be involved in regulating Psn function and that further characterization of the interaction between psn, APP, and ACE might aid our understanding of AD pathogenesis and the potential of ACE-Is for AD therapeutic development. This evidence concerns the gene APP and Alzheimer disease.